![Paul Ronald Bell](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Paul Ronald Bell
Directeur/Membre du Conseil chez
BIOTA HOLDINGS LTD.
Profil
Paul Ronald Bell currently works at Biota Holdings Pty Ltd., as Independent Non-Executive Director from 2012 and Westmead Millennium Institute for Medical Research, as Director.
Mr. Bell also formerly worked at Cochlear Ltd., as Non-Executive Director from 2011 to 2014, Novozymes Biopharma AU Ltd., as Director from 2003 to 2006, Merck Sharp & Dohme (Australia) Pty Ltd., as Managing Director, Bio-Link Partners Ltd., as Director from 2005 to 2009, Aviragen Therapeutics, Inc., as Non-Executive Director from 2012 to 2013, Merck & Co., Inc., as President-Asia Pacific Human Health Division in 2002, and The Garvan Institute of Medical Research, as Member-Pharmaceutical Partnerships Program.
Mr. Bell received his graduate degree from the University of Canterbury.
Postes actifs de Paul Ronald Bell
| Sociétés | Poste | Début |
|---|---|---|
| BIOTA HOLDINGS LTD. | Directeur/Membre du Conseil | 28/07/2009 |
Westmead Millennium Institute for Medical Research | Directeur/Membre du Conseil | - |
Anciens postes connus de Paul Ronald Bell
| Sociétés | Poste | Fin |
|---|---|---|
| COCHLEAR LIMITED | Directeur/Membre du Conseil | 14/10/2014 |
Aviragen Therapeutics, Inc.
 Aviragen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an anti-infective drug development company | Directeur/Membre du Conseil | 01/05/2013 |
| MERCK & CO., INC. | Corporate Officer/Principal | 01/01/2002 |
Novozymes Biopharma AU Ltd.
 Novozymes Biopharma AU Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Directeur/Membre du Conseil | - |
Bio-Link Partners Ltd.
 Bio-Link Partners Ltd. Miscellaneous Commercial ServicesCommercial Services Operates biotechnology business development company | Directeur/Membre du Conseil | - |
Formation de Paul Ronald Bell
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
68
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Cochlear Ltd.
 Cochlear Ltd. Medical SpecialtiesHealth Technology Develops, manufactures and markets implantable hearing solutions | Health Technology |
Biota Holdings Pty Ltd.
 Biota Holdings Pty Ltd. Pharmaceuticals: MajorHealth Technology Operates as an anti infective drug development company | Health Technology |
Novozymes Biopharma AU Ltd.
Novozymes Biopharma AU Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
University of Canterbury
 University of Canterbury Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Garvan Institute of Medical Research
 The Garvan Institute of Medical Research Miscellaneous Commercial ServicesCommercial Services Provides biomedical research | Commercial Services |
Merck Sharp & Dohme (Australia) Pty Ltd.
 Merck Sharp & Dohme (Australia) Pty Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Bio-Link Partners Ltd.
Bio-Link Partners Ltd. Miscellaneous Commercial ServicesCommercial Services Operates biotechnology business development company | Commercial Services |
Westmead Millennium Institute for Medical Research | |
Aviragen Therapeutics, Inc.
Aviragen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an anti-infective drug development company | Health Technology |
